Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal methylene blue for discogenic chronic axial low back pain
NL-OMON46869Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in discogenic back pain comparing Methylene blue arm with Sham/placebo arm (2 arms). Primary endpoints: Pain intensity at 6 months, Patient Global Impression of Change at 6 months and 1 more. Started Apr 2011; status: active, not recruiting.
02
Drugs
methylene blue
03
Conditions
discogenic back pain
Beyond the preview
Go deeper on NL-OMON46869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46869.